| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 01/03/2008 | WO2008002674A2 Bicyclic compositions and methods for modulating a kinase cascade |
| 01/03/2008 | WO2008001959A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 01/03/2008 | WO2008001752A1 Treatment of chronic obstructive pulmonary disease by statin |
| 01/03/2008 | WO2008001718A1 Dehydroxylated fluorinating agent |
| 01/03/2008 | WO2007103389A3 Aldolases, nucleic acids encoding them and methods for making and using them |
| 01/03/2008 | US20080004452 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 01/03/2008 | US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 01/03/2008 | US20080004304 Aryl Spirolactam Cgrp Receptor Antagonists |
| 01/03/2008 | US20080004301 Benzene Compound Having 2 or More Substituents |
| 01/03/2008 | US20080004290 Anti-Cancer Agents |
| 01/03/2008 | US20080004274 Novel biaromatic compounds that modulate PPAR type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/03/2008 | US20080004272 Compositions and methods for modulating gated ion channels |
| 01/03/2008 | US20080004262 2,2,7,9-tetramethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol; 3-hydroxy-2,2,9-trimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-7-carbonitrile; have the prolongation effect on refractory period |
| 01/03/2008 | US20080004241 Bicyclic compositions and methods for modulating a kinase cascade |
| 01/03/2008 | US20080004239 Boronated Metal-Phthalocyanines, Process For Their Preparation, Pharmaceutical Compositions Comprising Them And Use Thereof |
| 01/03/2008 | DE102005061756B4 Verbessertes Verfahren zur Herstellung von Ramipril An improved process for the preparation of Ramipril |
| 01/03/2008 | CA2656165A1 Bicyclic compositions and methods for modulating a kinase cascade |
| 01/03/2008 | CA2655913A1 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility |
| 01/02/2008 | EP1873144A1 Fused heterocyclic compound |
| 01/02/2008 | EP1871739A1 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 01/02/2008 | EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 01/02/2008 | EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 01/02/2008 | EP1406859B1 Substituted 4-aminocyclohexanol derivatives |
| 01/02/2008 | EP1268404B1 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 01/02/2008 | EP1263716B1 Amino acid derivatives as hiv aspartyl protease inhibitors |
| 01/02/2008 | CN101099286A Method and installation means for installing an electrical machine |
| 01/02/2008 | CN101098868A Substituted indoles, compositions containing them, method for the production thereof and their use |
| 01/02/2008 | CN101096357A Tetrabenzene methane derivative and its application |
| 01/02/2008 | CN100358895C One-step synthesis process for pemetrexed disodium key intermediate |
| 01/02/2008 | CN100358869C Carbamate caspase inhibitors and uses thereof |
| 01/02/2008 | CN100358868C Synthesis of phenolic monomers contg. imide or diimide moieties and high heat carbonate polymers prepared therefrom |
| 01/02/2008 | CN100358867C Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
| 01/01/2008 | US7314950 Sulfinating a trans-alkyl 4-aminocyclohexanecarboxylate (formed by iminating the cis-analog with a benzaldehyde and hydrolyzing the product) with an alkanesulfinyl chloride and oxidizing the product to form an alkyl 4-alkylsulfonamidocyclohexanecarboxylate, which then may be hydrolyzed |
| 01/01/2008 | US7314932 Methods for minimizing thioamide impurities |
| 01/01/2008 | US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1 |
| 01/01/2008 | US7314887 Thrombopoietin activity modulating compounds and methods |
| 01/01/2008 | US7314879 N-Acylpiperazine derivatives for obesity, diabetes, and erectile dysfunction treatment; sexual disorders |
| 01/01/2008 | US7314872 Selective in presence of at least one other cathepsin isozyme; such as morpholine-4-carboxylic acid {2-cyclopentyl-1--[2-(4-methoxy-phenylamino)-1--methyl-ethylcarbamoyl]-ethyl}-amide |
| 12/27/2007 | WO2007149033A1 Substituted isoindoles as bace inhibitors and their use |
| 12/27/2007 | WO2007148775A1 Chain amine compound |
| 12/27/2007 | WO2007147771A2 Tetralin and indane derivatives and uses thereof |
| 12/27/2007 | WO2007099402A3 New 3’-, 7-substituted indirubins and their applications |
| 12/27/2007 | WO2007047306A8 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 12/27/2007 | WO2006128142A8 Inhibitors of cytosolic phospholipase a2 |
| 12/27/2007 | WO2004058735A3 Ligands of melanocortin receptors and compositions and methods related thereto |
| 12/27/2007 | US20070299266 Crystal of Two-Ring Heterocyclic Sulfonamide Compound |
| 12/27/2007 | US20070299263 Hydroxy Alkyl Amines |
| 12/27/2007 | US20070299128 Use of Tryptophan Derivatives for the Specific Cytostatic Treatment of Serotonin-Producing Tumors |
| 12/27/2007 | US20070299126 Substituted pyrrole-indoles |
| 12/27/2007 | US20070299125 Substituted indoles |
| 12/27/2007 | US20070299123 Amorphous frovatriptan succinate and process for the preparation thereof |
| 12/27/2007 | US20070299114 Biaryl Derivatives |
| 12/27/2007 | US20070299105 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use |
| 12/27/2007 | US20070299102 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer |
| 12/27/2007 | US20070299101 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
| 12/27/2007 | US20070299077 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 12/27/2007 | US20070299073 Imidazolyl derivatives |
| 12/27/2007 | US20070299070 Such as 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-indole-2-carboxamide and 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-benzimidazole-2-carboxamide; melanin-concentrating hormone receptor antagonist, useful for treating obesity |
| 12/27/2007 | US20070299069 Methods for treating hepatitis C |
| 12/27/2007 | US20070299068 viricides comprising (3-cyano-indol-2-yl)phenyl derivatives, used for for treating viral diseases and infections or for affecting viral internal ribosome entry site (IRES) activity |
| 12/27/2007 | US20070298969 used as pesticides and/or pre- or postemergence herbicides |
| 12/27/2007 | US20070298968 2,4,6-Phenyl-Substituted Cyclic Ketoenols |
| 12/27/2007 | US20070298507 Fluorescent Probe |
| 12/27/2007 | US20070296332 Organometallic complexes as phosphorescent emitters in organic LEDs |
| 12/27/2007 | US20070296331 Aromatic amine derivative and organic electroluminescence device using the same |
| 12/27/2007 | CA2656625A1 Substituted isoindoles as bace inhibitors and their use |
| 12/27/2007 | CA2653758A1 Tetralin and indane derivatives and uses thereof |
| 12/26/2007 | EP1870400A1 Salts and crystalline salt forms of an 2-indolinone derivative |
| 12/26/2007 | EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors |
| 12/26/2007 | EP1869052A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors |
| 12/26/2007 | EP1868995A1 Copper complexes |
| 12/26/2007 | EP1751138B1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
| 12/26/2007 | EP1711465B1 Hydroisoindoline tachykinin receptor antagonists |
| 12/26/2007 | EP1685104B1 Processes for the preparation of n-substituted phthalimides |
| 12/26/2007 | EP1597248B1 Sulfonamide derivatives as ppar modulators |
| 12/26/2007 | CN101094861A Agonists and antagonists of the somatostatin receptor |
| 12/26/2007 | CN101092389A Method for preparing Anthracene and Carbazole in high purity by rectifying crude anthracene |
| 12/26/2007 | CN101092388A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
| 12/26/2007 | CN101092387A Method for preparing Sumatriptan Succinate |
| 12/26/2007 | CN101092386A New article type of Perindopril |
| 12/26/2007 | CN101091923A Carbon nitrogen coupling reaction catalyst composed of heterocycle functional group 1,3 diketone and halogenated univalence copper, and preparation method |
| 12/26/2007 | CN100357271C Hole transport materials with 9-phenyl carbazole as core and process for making same |
| 12/26/2007 | CN100356979C Integrin expression inhibitors |
| 12/25/2007 | US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 12/25/2007 | US7312342 Process for the preparation of (3-cyano-1h-indol-7-yl) (4-(4-fluorophenethyl) piperazin-1-yl)-methanone and salts thereof |
| 12/25/2007 | US7312341 Kinase inhibitors; rheumatic diseases; antiarthritic agents |
| 12/25/2007 | US7312339 cytotoxic agents; made by fermentation of Streptomyces sparsogenes |
| 12/25/2007 | US7312230 Carboxylic acid derivatives as IP antagonists |
| 12/25/2007 | US7312214 Anticoagulants; atherosclerosis; strokes; thrombosis; cardiovascular disorders |
| 12/25/2007 | US7312203 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |
| 12/21/2007 | WO2007146715A1 Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide |
| 12/21/2007 | WO2007144281A1 Process for alkenylating carboxamides |
| 12/21/2007 | WO2007143825A1 Indoline amide derivatives as ep4 receptor ligands |
| 12/21/2007 | WO2007125547A9 Novel process for statins and its pharmaceutically acceptable salts thereof |
| 12/21/2007 | WO2007106469A3 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders |
| 12/21/2007 | WO2007062078A3 Thrombopoietin activity modulating compounds and methods |
| 12/21/2007 | WO2002072068A3 Lipids, lipid compositions, liposomes, and lipoplexes |
| 12/21/2007 | CA2654927A1 Substituted phenyl acetic acids as dp-2 antagonists |
| 12/21/2007 | CA2654811A1 Indoline amide derivatives as ep4 receptor ligands |
| 12/21/2007 | CA2654439A1 Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide |